Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telmisartan vs Valsartan for Neointima Volume in Diabetes
NCT00599885Phase 4Completed
- Sponsor
- Korea University Anam Hospital
- Start
- Sep 2007
- Primary completion
- Jul 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of telmisartan in coronary artery disease (CAD) and hypertension (HTN) (2 arms), sponsored by Korea University Anam Hospital. Primary endpoint: Neointima Volume with IVUS at 8 months. Started Sep 2007; status: completed.
02
Drugs
telmisartan
03
Conditions
coronary artery disease (CAD)hypertension (HTN)
Beyond the preview
Go deeper on NCT00599885.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00599885.